Sanofi-aventis and Health Canada are notifying healthcare professionals about the potential for serious liver injury with Multaq (dronedarone), including rare cases of hepatic failure.
With the aid of coronary CT angiography (cCTA), researchers may have found a better way to identify heart disease in African-Americans and in certain obese individuals.
